Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 3, 2013, Pages 978-983

  Zhang, Qin ^a   Spears, Erick ^a   Boone, David N ^b   Li, Zhaoliang ^a   Gregory, Mark A ^c   Hanna, Stephen R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer; Oncogene

Indexed keywords

ARF PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; MYC PROTEIN; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BINDING, COMPETITIVE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EARLY GROWTH RESPONSE PROTEIN 1; GENE KNOCKOUT TECHNIQUES; GENES, MYC; HELA CELLS; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84872548776     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1208334110     Document Type: Article

References (34)

1. Lüscher B, Vervoorts J (2012) Regulation of gene transcription by the oncoprotein MYC. Gene 494(2):145-160.
2. Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8(12):976-990.
3. Sherr CJ, et al. (2005) p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 70:129-137. (Pubitemid 44124864)
4. Qi Y, et al. (2004) p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431(7009):712-717. (Pubitemid 39382620)
5. GregoryMA, Qi Y, Hann SR (2005) The ARF tumor suppressor: Keeping Myc on a leash. Cell Cycle 4(2):249-252. (Pubitemid 41365328)
6. Boone DN, Qi Y, Li Z, Hann SR (2011) Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci USA 108(2):632-637.
7. Li Z, Hann SR (2009) The Myc-nucleophosmin-ARF network: A complex web unveiled. Cell Cycle 8(17):2703-2707.
8. Chan CH, Lee SW, Wang J, Lin HK (2010) Regulation of Skp2 expression and activity and its role in cancer progression. Scientific World Journal 10:1001-1015.
9. Dominguez-Brauer C, Brauer PM, Chen YJ, Pimkina J, Raychaudhuri P (2010) Tumor suppression by ARF: Gatekeeper and caretaker. Cell Cycle 9(1):86-89.
10. Rizos H, Scurr LL, Irvine M, Alling NJ, Kefford RF (2007) p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism. Cell Cycle 6(14):1741-1747. (Pubitemid 47327927)
11. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP (2003) Skp2 regulates Myc protein stability and activity. Mol Cell 11(5):1177-1188. (Pubitemid 36645138)
12. von der Lehr N, et al. (2003) The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11(5):1189-1200.
13. Welcker M, et al. (2004) The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101(24):9085-9090. (Pubitemid 38781615)
14. Yada M, et al. (2004) Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 23(10):2116-2125. (Pubitemid 38737738)
15. Popov N, Schülein C, Jaenicke LA, Eilers M (2010) Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol 12(10):973-981.
16. Hemann MT, et al. (2005) Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436(7052):807-811. (Pubitemid 41160633)
17. Adhikary S, et al. (2005) The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123(3):409-421. (Pubitemid 41546672)
18. Muller J, Eilers M (2008) Ubiquitination of Myc: Proteasomal degradation and beyond. Ernst Schering Found Symp Proc 1:99-113.
19. Thomas LR, Tansey WP (2011) Proteolytic control of the oncoprotein transcription factor Myc. Adv Cancer Res 110:77-106.
20. Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44(2):325-340.
21. Salghetti SE, Kim SY, Tansey WP (1999) Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J 18(3):717-726. (Pubitemid 29057256)
22. Gregory MA, Hann SR (2000) c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20(7):2423-2435. (Pubitemid 30152050)
23. Choi SH, Wright JB, Gerber SA, Cole MD (2010) Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 24(12):1236-1241.
24. Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC (2005) A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc Natl Acad Sci USA 102(42):15195-15200. (Pubitemid 41513358)
25. Reed SI (2008) Deathproof: new insights on the role of skp2 in tumorigenesis. Cancer Cell 13(2):88-89.
26. Joslin JM, et al. (2007) Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 110(2):719-726. (Pubitemid 47105411)
27. Liu J, et al. (2007) Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells. Cancer Genomics Proteomics 4(6):377-385.
28. Weber JD, et al. (2000) p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 14(18):2358-2365.
29. Bretones G, et al. (2011) SKP2 oncogene is a direct MYC target gene and MYC downregulates p27(KIP1) through SKP2 in human leukemia cells. J Biol Chem 286(11):9815-9825.
30. Zhu L (2010) Skp2 knockout reduces cell proliferation and mouse body size: And prevents cancer? Cell Res 20(6):605-607.
31. Liu J, Tan L, Li H, Wang Q, Ji W (2010) Suppression of S-phase kinase-associated protein 2 induces apoptosis and inhibits tumor growth in human laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 72(4):205-214.
32. Lee SH, McCormick F (2005) Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med (Berl) 83(4):296-307. (Pubitemid 40674956)
33. Li Z, Boone D, Hann SR (2008) Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci USA 105(48):18794-18799.
34. Spotts GD, Patel SV, Xiao Q, Hann SR (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by fulllength c-Myc proteins. Mol Cell Biol 17(3):1459-1468. (Pubitemid 27097375)